ArticleCancer medicine2022

Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.

Yuki Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.